Published on in Vol 9 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/58163, first published .
Components of a Digital Storytelling Intervention for Human Papillomavirus and Cancer Prevention Among LGBTQ+ Individuals: Formative Mixed Methods Inquiry

Components of a Digital Storytelling Intervention for Human Papillomavirus and Cancer Prevention Among LGBTQ+ Individuals: Formative Mixed Methods Inquiry

Components of a Digital Storytelling Intervention for Human Papillomavirus and Cancer Prevention Among LGBTQ+ Individuals: Formative Mixed Methods Inquiry

1Department of Public Health, Mercer University, 3001 Mercer University Drive, Atlanta, GA, United States

2College of Pharmacy, Mercer University, Atlanta, GA, United States

3Institute of Higher Education, University of Georgia, Athens, GA, United States

4School of Nursing, Yale University, West Haven, CT, United States

5Empowerment Resource Center, Atlanta, GA, United States

*all authors contributed equally

Corresponding Author:

Gabrielle Darville-Sanders, MPH, PhD, CHES


Background: Human papillomavirus (HPV) is one of the most prevalent sexually transmitted infections in the United States; however, vaccination uptake falls far below the goal of 80% of the population set forth by Healthy People 2030. Specifically, within the LGBTQ+ (lesbian, gay, bisexual, transgender, queer/questioning) population, HPV vaccination adherence remains a complex issue. Due to the widespread use of technology within the young adult population, digital health tools such as digital storytelling (DST) have been promoted as an effective way to increase vaccination uptake.

Objective: The purpose of this study was to conduct a formative inquiry into (1) what components should be considered for inclusion in an HPV documentary tailored for sexual and gender minority populations and (2) what dissemination channels would be more effective and impact the uptake and completion of the HPV vaccine among sexual and gender minority populations. Additionally, this study aims to provide insight into perceived HPV risk and its implications on the HPV vaccine uptake within the LGBTQ+ population.

Methods: A mixed methods study was conducted between January 2021 and September 2021 in Atlanta, Georgia. Intake surveys were distributed to individuals identifying as members of the LGBTQ+ community to examine demographic characteristics, barriers to vaccine adherence, and current HPV vaccination status. Perceived HPV risk was assessed using 5 statements on a 1 to 7 Likert scale. Key informant interviews were conducted via Zoom with participants who completed the intake surveys and consented to be interviewed. Transcripts were coded and analyzed using the constant comparison method for emergent themes surrounding components of effective DST campaigns.

Results: Forty-seven individuals completed the intake survey and interview. A total of 13 out of 47 (27.7%) of participants indicated that they were not sure when provided with the statement “I am likely to get HPV”, whereas 12 out of 47 (29.8%) participants strongly disagreed with the statement “I am at high risk for getting HPV” and 13 out of 47 (27.7%) participants indicated that they were not sure when presented with the statement “HPV would be a serious threat to the quality of my life.” A total of 14 out of 47 (29.8%) participants responded that they were not sure to the statement “HPV would be a severe threat to my health” and 13 out of 47 (27.7%) participants strongly agreed that “HPV would be a severe threat to my sex life.” Qualitative analysis indicated a high level of stigma experienced in interactions between the LGBTQ+ population and private practitioners. Major barriers to vaccination hesitancy were concerns about age, perceived reduced risk, and lack of provider recommendation. Participant interviews revealed that “Real Outcomes,” and “Accurate Representation” were the main components that should be considered for inclusion in an HPV documentary tailored for sexual and gender minority populations.

Conclusions: Creation of a DST intervention within the LGBTQ+ population should include information surrounding the real outcomes of HPV and accurate representation.

JMIR Form Res 2025;9:e58163

doi:10.2196/58163

Keywords



Vaccines have proven to be an effective primary public health measure towards preventing disease, disability, and death from infectious diseases [Nandi A, Shet A. Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination. Hum Vaccin Immunother. Aug 2, 2020;16(8):1900-1904. [CrossRef] [Medline]1-Rodrigues CMC, Plotkin SA. Impact of vaccines; health, economic and social perspectives. Front Microbiol. 2020;11:1526. [CrossRef] [Medline]3]. Vaccination is not only vital to individual health, but also a crucial component of improving the health of communities by reducing the spread of disease. Human papillomavirus (HPV) is the most prevalent sexually transmitted infection in the United States, with a prevalence of 40% among persons aged 15‐59 years [Hirth J. Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother. 2019;15(1):146-155. [CrossRef] [Medline]4]. It is also responsible for a significant amount of morbidity and mortality [Lewis RM, Laprise JF, Gargano JW, et al. Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States. Sex Transm Dis. Apr 1, 2021;48(4):273-277. [CrossRef] [Medline]5,McClung NM, Gargano JW, Park IU, et al. Estimated number of cases of high-grade cervical lesions diagnosed among women - United States, 2008 and 2016. MMWR Morb Mortal Wkly Rep. Apr 19, 2019;68(15):337-343. [CrossRef] [Medline]6]. Despite disease prevalence, HPV vaccination uptake has fallen short of 80% of the general population, a goal set forth by Healthy People 2030 [Chido-Amajuoyi OG, Jackson I, Yu R, Shete S. Declining awareness of HPV and HPV vaccine within the general US population. Hum Vaccin Immunother. Feb 1, 2021;17(2):420-427. [CrossRef] [Medline]7].

The World Health Organization identified complacency, inconvenience, and lack of confidence as several of the various factors that can influence an individual’s intention to become vaccinated. These factors, when not addressed, result in vaccine uncertainty or delayed vaccination and the overall undermining of public health efforts due to decreased vaccine coverage and an increased risk of disease outbreaks [Etowa J, Beauchamp S, Fseifes M, et al. Understanding low vaccine uptake in the context of public health in high-income countries: a scoping review. Vaccines (Basel). Mar 4, 2024;12(3):269. [CrossRef] [Medline]8]. Vaccination hesitancy is not a new problem [Alcendor DJ. Targeting COVID vaccine hesitancy in rural communities in Tennessee: implications for extending the COVID-19 pandemic in the south. Vaccines (Basel). Nov 4, 2021;9(11):1279. [CrossRef] [Medline]9-Oostvogel PM, van Wijngaarden JK, van der Avoort HG, et al. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet. Sep 3, 1994;344(8923):665-670. [CrossRef] [Medline]12]and has been recognized by the World Health Organization as a top 10 threat to global health [Hou Z, Tong Y, Du F, et al. Assessing COVID-19 vaccine hesitancy, confidence, and public engagement: a global social listening study. J Med Internet Res. Jun 11, 2021;23(6):e27632. [CrossRef] [Medline]13-Ten health issues WHO will tackle this year. World Health Organization. URL: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 [Accessed 2023-09-21] 15]. Controversy has consistently surrounded the measles, mumps and rubella vaccine [Nuwarda RF, Ramzan I, Weekes L, Kayser V. Vaccine hesitancy: contemporary issues and historical background. Vaccines (Basel). Sep 22, 2022;10(10):1595. [CrossRef] [Medline]14], diphtheria, tetanus and pertussis vaccine [Nuwarda RF, Ramzan I, Weekes L, Kayser V. Vaccine hesitancy: contemporary issues and historical background. Vaccines (Basel). Sep 22, 2022;10(10):1595. [CrossRef] [Medline]14,Kulenkampff M, Schwartzman JS, Wilson J. Neurological complications of pertussis inoculation. Arch Dis Child. Jan 1974;49(1):46-49. [CrossRef] [Medline]16], swine flu vaccine [Nuwarda RF, Ramzan I, Weekes L, Kayser V. Vaccine hesitancy: contemporary issues and historical background. Vaccines (Basel). Sep 22, 2022;10(10):1595. [CrossRef] [Medline]14,GBS (guillain-barré syndrome) and vaccines | vaccine safety. Center for Disease Control. URL: https://www.cdc.gov/vaccinesafety/concerns/guillain-barre-syndrome.html [Accessed 2023-09-21] 17], polio vaccine [Nuwarda RF, Ramzan I, Weekes L, Kayser V. Vaccine hesitancy: contemporary issues and historical background. Vaccines (Basel). Sep 22, 2022;10(10):1595. [CrossRef] [Medline]14,Historical safety concerns | vaccine safety. Center for Disease Control. URL: https://www.cdc.gov/vaccinesafety/concerns/concerns-history.html [Accessed 2023-09-21] 18], influenza vaccine [Stephens AB, Hofstetter AM, Stockwell MS. Influenza vaccine hesitancy: scope, influencing factors, and strategic interventions. Pediatr Clin North Am. Apr 2023;70(2):227-241. [CrossRef] [Medline]19], and most recently the COVID-19 vaccine [Alcendor DJ. Targeting COVID vaccine hesitancy in rural communities in Tennessee: implications for extending the COVID-19 pandemic in the south. Vaccines (Basel). Nov 4, 2021;9(11):1279. [CrossRef] [Medline]9,Hou Z, Tong Y, Du F, et al. Assessing COVID-19 vaccine hesitancy, confidence, and public engagement: a global social listening study. J Med Internet Res. Jun 11, 2021;23(6):e27632. [CrossRef] [Medline]13,Rittle C. COVID-19 vaccine hesitancy and how to address it. Workplace Health Saf. Feb 2022;70(2):56-62. [CrossRef] [Medline]20,Yasmin F, Najeeb H, Moeed A, et al. COVID-19 vaccine hesitancy in the United States: a systematic review. Front Public Health. 2021;9:770985. [CrossRef] [Medline]21]; affecting adherence of the general population. Similarly, the HPV vaccine has also seen low levels of initial uptake and moderate levels of series completion [Amantea C, Foschi N, Gavi F, et al. HPV vaccination adherence in working-age men: a systematic review and meta-analysis. Vaccines (Basel). Feb 15, 2023;11(2):443. [CrossRef] [Medline]22,Ejezie CL, Osaghae I, Ayieko S, Cuccaro P. Adherence to the recommended HPV vaccine dosing schedule among adolescents aged 13 to 17 years: findings from the national immunization survey-teen, 2019-2020. Vaccines (Basel). Apr 8, 2022;10(4):577. [CrossRef] [Medline]23]. In 2016, only 60% of 13‐17-year-olds completed 1 dose of the vaccine series [Bednarczyk RA, Ellingson MK, Omer SB. Human papillomavirus vaccination before 13 and 15 years of age: analysis of national immunization survey teen data. J Infect Dis. Jul 31, 2019;220(5):730-734. [CrossRef] [Medline]24], and less than 50% of teens were up to date with the recommended HPV vaccination series [Hirth J. Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother. 2019;15(1):146-155. [CrossRef] [Medline]4,Bednarczyk RA, Ellingson MK, Omer SB. Human papillomavirus vaccination before 13 and 15 years of age: analysis of national immunization survey teen data. J Infect Dis. Jul 31, 2019;220(5):730-734. [CrossRef] [Medline]24,Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2016. MMWR Morb Mortal Wkly Rep. Aug 25, 2017;66(33):874-882. [CrossRef] [Medline]25]. Furthermore, major disparities surrounding geography [Hirth JM, Rahman M, Smith JS, Berenson AB. Regional variations in HPV vaccination among 9–17 year old adolescent females from the BRFSS, 2008–2010. Hum Vaccines Immunother. Dec 2, 2014;10(12):3475-3483. [CrossRef]26,Rahman M, McGrath CJ, Berenson AB. Geographic variation in human papillomavirus vaccination uptake among 13-17 year old adolescent girls in the United States. Vaccine (Auckl). May 1, 2014;32(21):2394-2398. [CrossRef] [Medline]27], economic status, educational level [Kurani S, MacLaughlin KL, Jacobson RM, et al. Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake. Vaccine (Auckl). Jan 24, 2022;40(3):471-476. [CrossRef] [Medline]28], and health care provider recommendations [Rosen BL, Shepard A, Kahn JA. US health care clinicians’ knowledge, attitudes, and practices regarding human papillomavirus vaccination: a qualitative systematic review. Acad Pediatr. Mar 2018;18(2S):S53-S65. [CrossRef] [Medline]29] have been found to be correlated with HPV vaccination.

Various strategies have been used to address vaccine hesitancy, such as peer mentoring [Esaggoff A, Cohen, S, Chang G, Equils O, Orman SV, Burnett A. 2531. using peer-to-peer education to increase awareness and uptake of HPV vaccine among Chinese international students. Open Forum Infect Dis. Oct 23, 2019;6(Supplement_2):S879-S880. [CrossRef]30-Ganczak M, Pasek O, Duda-Duma Ł, Komorzycka J, Nowak K, Korzeń M. A peer-based educational intervention effects on SARS-CoV-2 knowledge and attitudes among Polish high-school students. Int J Environ Res Public Health. Nov 20, 2021;18(22):12183. [CrossRef] [Medline]32] and workshops/lectures [Tutt M, Begay C, George S, et al. Diné teachings and public health students informing peers and relatives about vaccine education: providing Diné (Navajo)-centered COVID-19 education materials using student health messengers. Front Public Health. 2022;10:1046634. [CrossRef] [Medline]33]. One of the more novel ideas, however, has been that of digital storytelling (DST). The participatory nature of DST has significant potential to promote participants’ psychosocial health and well-being, revealing hidden stories and initiating community dialogue about issues that are pressing and concerning to research participants [Rieger KL, West CH, Kenny A, et al. Digital storytelling as a method in health research: a systematic review protocol. Syst Rev. Mar 5, 2018;7(1):41. [CrossRef] [Medline]34]. Furthermore, DST as a medium can decrease the time between knowledge generation and implementation [Rieger KL, West CH, Kenny A, et al. Digital storytelling as a method in health research: a systematic review protocol. Syst Rev. Mar 5, 2018;7(1):41. [CrossRef] [Medline]34]. Given the high use of technology among young adults [Villanti AC, Johnson AL, Ilakkuvan V, Jacobs MA, Graham AL, Rath JM. Social media use and access to digital technology in US young adults in 2016. J Med Internet Res. Jun 7, 2017;19(6):e196. [CrossRef] [Medline]35], digital health technologies have been touted as an effective way to encourage uptake among this group [Lehtimaki S, Martic J, Wahl B, Foster KT, Schwalbe N. Evidence on digital mental health interventions for adolescents and young people: systematic overview. JMIR Ment Health. Apr 29, 2021;8(4):e25847. [CrossRef] [Medline]36,Young people and digital health interventions: working together to design better. World Health Organization. URL: https:/​/www.​who.int/​news/​item/​29-10-2020-young-people-and-digital-health-interventions-working-together-to-design-better [Accessed 2024-03-05] 37]. In DST, participants describe their personal stories to an audience that is specific to a lived experience. On the other side, the audience is influenced by the story through their own relevant feelings or responses [Rieger KL, West CH, Kenny A, et al. Digital storytelling as a method in health research: a systematic review protocol. Syst Rev. Mar 5, 2018;7(1):41. [CrossRef] [Medline]34]. This model has been investigated by researchers to ascertain whether or not it can be effective in regard to the distrust surrounding the COVID vaccine among Black Americans [Budhwani H, Maragh-Bass AC, Tolley EE, et al. Tough talks COVID-19 digital health intervention for vaccine hesitancy among Black young adults: protocol for a hybrid type 1 effectiveness implementation randomized controlled trial. JMIR Res Protoc. Feb 13, 2023;12(1):e41240. [CrossRef] [Medline]38]. Kim et al [Kim M, Lee H, Kiang P, et al. A storytelling intervention in a mobile, web-based platform: a pilot randomized controlled trial to evaluate the preliminary effectiveness to promote human papillomavirus vaccination in Korean American college women. Health Educ Behav. Apr 2020;47(2):258-263. [CrossRef] [Medline]39] used DST as a means to promote HPV vaccination among Korean American College women and found the intervention to result in improvement in knowledge and attitude at the conclusion of the intervention. Additionally, in their study, the experimental group was twice as likely to receive the HPV vaccine as the comparison group. A similar intervention was conducted by Chen et al [Chen ACC, Kim WS, Todd M, Larkey L. A digital storytelling intervention for Vietnamese American mothers to promote their children’s HPV vaccination. Cancer Prev Res (Phila). Jul 5, 2022;15(7):465-472. [CrossRef] [Medline]40] in which they found DST to be effective in increasing Korean mothers’ intention to vaccinate their children against HPV (from 53% to 74%).

Despite the well-documented success of DST, there remain several limitations to its use. Ethical challenges can arise with the use of DST, specifically regarding the use of participant photographs and voices, which can result in issues with the maintenance of participant confidentiality [Rieger KL, West CH, Kenny A, et al. Digital storytelling as a method in health research: a systematic review protocol. Syst Rev. Mar 5, 2018;7(1):41. [CrossRef] [Medline]34]. There also remains a gap in the use of DST specifically in relation to the LGBTQ+ (lesbian, gay, bisexual, transgender, queer/questioning) population. There is a pattern of discrimination, stigma, and lack of awareness among health care providers, along with issues surrounding access to sex education, health care, and insurance coverage that have impeded LGBTQ+ populations from accessing health care services and thus contributed to major disparities surrounding HPV and HPV vaccination [Carpenter E. “The Health System Just Wasn’t Built for Us”: queer cisgender women and gender expansive individuals’ strategies for navigating reproductive health care. Womens Health Issues. 2021;31(5):478-484. [CrossRef] [Medline]41-Ward BW, Dahlhamer JM, Galinsky AM, Joestl SS. Sexual orientation and health among U.S. adults: national health interview survey, 2013. Natl Health Stat Report. Jul 15, 2014;(77):1-10. [Medline]47]. The purpose of this study was to conduct a formative inquiry into (1) what components should be considered for inclusion in an HPV documentary tailored for sexual and gender minority populations, and (2) what dissemination channels would be more effective and impact the uptake and completion of the HPV vaccine among sexual and gender minority populations. Thus, informing the construction of a DST intervention to increase HPV vaccine uptake within the LGBTQ+ population. Additionally, this study aims to provide insight into the influence that perception of HPV risk can have on HPV vaccine uptake.


Study Design

This mixed method, explanatory sequential study was conducted among individuals who identified as members of the LGBTQ+ community between January 2021 and September 2021 in Atlanta, Georgia.

Ethical Considerations

This study was conducted according to the guidelines 2018 Federal Regulations 21 CFR 56.110(b) and 45 CFR 46.110(b) (for expedited review) and was approved under categories _6, _7 per 63 FR 60364. All procedures involving research study participants were approved by the Mercer University Institutional Review Board on April 2, 2020. Written informed consent was obtained from all participants.

On the opening page of the survey, participants were presented with information about the study’s objectives and scope, followed by an informed consent statement. Participants were free to withdraw at any point without consequence. In addition, participation was anonymous, and no personally identifiable information was collected or used. Informed consent was obtained from all participants involved in the study, in compliance with the H2004105 Mercer University Institutional Review Board protocol. Participants were compensated for their participation via a US $40 Amazon gift card for completion of both the intake survey and participant interview.

Participants

Participants were recruited using convenience sampling to recruit participants for the study. Using statewide organizational connections, community partnerships, web-based or email advertising, and word-of-mouth recruitment, 60 participants were recruited. Eligible participants were those aged 18 years or older, currently residing in Atlanta, Georgia, capable of providing informed consent before starting the survey, and identifying as members of the LGBTQ+ community.

After enrolling in the study via SuperSaaS software (SuperSaaS B.V.), survey participants were emailed the link to the Qualtrics survey with the informed consent and intake survey to complete prior to their interview participation. Participant information was deidentified using a participant identification number assigned to all registrants via the SuperSaaS software [SuperSaaS. URL: https://www.supersaas.com [Accessed 2024-03-07] 48]. Reminder emails were sent 1 week prior to the session, with follow-up emails sent 3 days before the interview session. Follow-up emails were sent to nonrespondents to encourage participation. If no response was received by the morning of the final day of data collection, those participants were removed from the study, resulting in a cohort of 47.

Procedure

Demographic data were obtained from the 15 initial intake questions distributed after participants had signed up for an interview session. The intake survey was distributed via Qualtrics, took approximately 5‐10 minutes to complete, and was developed with input from a subject matter expert specializing in LGBTQ populations. Scale items were adapted from a previous HPV study assessing 3 key constructs: risk perception (3 items), self-efficacy (3 items), and behavioral intention (4 items) using a 7-point Likert scale(1=strongly disagree to 7=strongly agree) [Katz ML, Kam JA, Krieger JL, Roberto AJ. Predicting human papillomavirus vaccine intentions of college-aged males: an examination of parents’ and son’s perceptions. J Am Coll Health. 2012;60(6):449-459. [CrossRef] [Medline]49]. The total score was calculated from the sum of the response items, with higher scores indicating a greater perceived risk of HPV. An additional LGBTQ-related demographic question was added, but was not revalidated or pretested.

Due to special precautions associated with the COVID-19 pandemic, all interviews were conducted via Zoom and lasted about 45 minutes. Three student researchers previously trained in qualitative data collection, ethics, and compliance were enlisted to facilitate the interviews. Student researchers verified that the informed consent and intake survey were completed prior to the start of the interview, and using the intake survey, we were able to capture demographic data from our sample. The interview protocol consisted of open-ended questions adapted from a similar study surrounding the initiation of pre-exposure prophylaxis amongst Black men who have sex with men [Thomas PD. A qualitative exploration of pre-exposure prophylaxis (PrEP) initiation decision-making among men who have sex with men (MSM): “It Definitely was A Process”. J Natl Black Nurses Assoc. Dec 2019;30(2):10-17. [Medline]50]. Two versions of the interview protocol were developed based on vaccination status. If participants indicated that they were vaccinated, their interview focused on the facilitators/motivating factors that encouraged them to do so. On the other hand, if indicated that they were not vaccinated, interview questions focused on the barriers to completing the vaccine series. Following the completion of the interviews, student researchers accessed the Zoom transcript files and cleaned them for data analysis.

Data Analysis

Descriptive statistics were computed for all variables using StataSE (version 14; StataCorp LLC). The total number of responses and percentages were reported for categorical variables; mean and standard deviation were reported for continuous variables.

Using NVivo software (QSR International), 2 researchers trained in qualitative data analysis and NVivo software technology coded the 47 interviews. Using the constant comparative method, a codebook was developed for thematic coding and analysis by the research team [Glaser BG. The constant comparative method of qualitative analysis. Soc Probl. Apr 1965;12(4):436-445. [CrossRef]51]. Additionally, to reduce bias and to establish interrater reliability, the researchers developed a schedule for coding and a coding scheme. Each week, the researchers would code 10% of the transcripts independently and then merge coding findings into one dataset. The research team would then meet to run a coding comparison query in NVivo. Any data set sample that reported an agreement less than 90% was discussed to ensure that each individual researcher understood the codes and associated definitions/applications. The data set was coded again by the researcher individually, and the process was replicated until 90%‐100% agreement was achieved. A coding agreement of 90%‐100% means that minimal to no disagreements were reported using kappa coefficient in NVivo and consensus was established [McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276-282. [CrossRef]52]. After coding was completed, the data were organized using NVivo software to explore emerging patterns and themes.

Positionality of the Research Team

The diverse racial, cultural, and professional backgrounds of the research team included Black Caribbean, Black US American, White US American, and Asian American. This diversity allowed for study participants to authentically express their thoughts and feel comfortable sharing their lived experiences. Four of the authors hold primary backgrounds in public health, with experiences in health equity, community-centered research, and systems-level changes that shaped the framing of research questions, participant response, and theme prioritization during the qualitative analysis, which enriched the study depth. The secondary author is a foreign-trained medical physician whose clinical experiences in low-resource settings shaped a unique understanding of the structural inequities within health care and the importance of the patient-physician relationship, allowing for a deeper contextual understanding of participant responses.

Furthermore, each author’s unique personal experiences shaped how we approached the research process, and we acknowledge that our diverse professional and cultural contexts may have introduced potential biases within the analysis. To avoid speaking for the data, the team used reflexivity and iterative discussions. This included note-taking, which allowed the team to document and bring to light preconceptions while simultaneously ensuring that our interpretations were grounded in participants’ voices. The team sought to ensure that our research findings were both ethically grounded and accurately interpreted through collaborative discussion and critical reflection.


Quantitative Findings

Although initially 60 participants signed up to participate, only 47 total interviews were conducted, resulting in a 78.33% completion rate. Demographic characteristics observed within our cohort were as follows: 51.1% (24/47) of the cohort were 27 years and older, and 48.9% (23/47) of the participants were White (Table 1). The breakdown concerning gender identity were as follows: 44.7% (21/47) of the participants identified as a man, 36.2% (28/47) of the participants identified as a woman, 6.4% (3/47) of the participants were nonbinary, and 4.3% (2/47) of the participants were gender fluid. A total of 29.8% (14/47) of the participants of our sample identified as gay, 19.1% (9/47) of the participants were bisexual, 14.9% (7/47) of the participants were lesbian, 12.8% (6/47) of the participants were pansexual, and 8.5% (4/47) of the participants were queer. In addition, 53.2% (25/47) of the participants indicated that they were single, and 19.1% (9/47) of the participants indicated that they were in a monogamous relationship. Around 74.5% (35/47) of the participants of our sample had been sexually active in the last 6 months, and 14.9% (7/47) of the participants engaged in unprotected sex of some kind. Thirty-six out of 47 (54.4%) participants indicated that their total lifetime partners were between 5 and 29 (54.4%) and 29.8% (14/47) of the participants never had a sexually transmitted disease. Forty-three out of 47 (91.5%) participants had not been diagnosed with HPV, and 28/33 (84.9%) participants tested indicated that they were HIV negative. Additionally, 22/47 participants (46.8%) indicated that they initiated the HPV vaccination.

Table 1. Demographic characteristics (N=47).
Values, n (%)
Age (years)
2010 (21.3)
21‐238 (17.0)
24‐265 (10.6)
27 and older24 (51.1)
Race and ethnicity
Asian2 (4.3)
Biracial or multiracial6 (12.8)
Black or African American14 (29.8)
Hispanic2 (4.3)
White or Caucasian23 (48.9)
Assigned sex at birth
Female28 (59.6)
Male19 (40.4)
Gender identity
Gender fluid2 (4.3)
Genderqueer1 (2.1)
Man21 (44.7)
Nonbinary3 (6.4)
Other or self-identify3 (6.4)
Woman17 (36.2)
Sexuality
Asexual2 (4.3)
Bisexual9 (19.1)
Gay14 (29.8)
Heterosexual1 (2.1)
Lesbian7 (14.9)
Pansexual6 (12.8)
Queer4 (8.5)
Questioning1 (2.1)
Other or self-identify3 (6.4)
Relationship status
Cohabitating4 (8.5)
Married or partnered9 (19.1)
Monogamous relationship (only dating one person)9 (19.1)
Single (not in a relationship)25 (53.2)
Sexually active (Last 6 mo)
No12 (25.5)
Yes35 (74.5)
Sexual behaviors (n=41)
Protected anal sex6 (12.8)
Unprotected anal sex9 (19.1)
Unprotected oral sex7 (14.9)
Unprotected vaginal sex12 (25.5)
Protected vaginal sex7 (14.9)
Lifetime sexual partners
1 to 411 (23.4)
5 to 77 (14.9)
8 to 147 (14.9)
15 to 2912 (25.5)
30 or more10 (21.3)
Have you ever been diagnosed with an STDa?
No33 (70.2)
Yes14 (29.8)
Have you ever been tested for HIV?
No14 (29.8)
Yes33 (70.2)
Have you ever been diagnosed with HPV?
No43 (91.5)
Yes4 (8.5)
Have you ever received any doses of the HPV Vaccine?
No25 (53.2)
Yes22 (46.8)
How many doses of the HPV vaccine have you received? (n=22)
1 dose2 (9.1)
2 doses5 (22.7)
All 3 doses15 (68.2)
HIV Status (n=33)
Confirmatory positive5 (10.6)
Negative28 (84.8)
What kind of insurance do you have?
Insurance through employer22 (46.8)
No insurance4 (8.5)
Other2 (4.3)
Private insurance9 (19.1)
Public or government sponsored8 (17.0)
Unsure2 (4.3)

aSTD: sexually transmitted disease.

Of our sample, 68.2% (15/47) of the participants indicated that they had completed the HPV vaccination series (3 doses received) and most 46.8% (22/47) of the participants had health insurance through an employer followed by 19.1% (9/47) of the participants having private insurance and 17.0% (8/47) of the participants being public/government sponsored (Table 1).

Risk for getting HPV (how susceptible they were to contracting the virus) was assessed using 5 statements on a 1 to 7 Likert scale (Table 2). When provided with the statement “I am likely to get HPV,” 27.66% (13/47) of our participants responded not sure, followed by 23.40% (11/47) of the participants who strongly disagreed. Overall, 29.79% (12/47) of our study sample strongly disagreed with the statement “I am at high risk for getting HPV” and 27.66% (13/47) of the participants indicated that they were not sure when presented with the statement “HPV would be a serious threat to the quality of my life.” A total of 29.79% (14/47) of the participants responded not sure to the statement “HPV would be a severe threat to my health and 27.66% (13/47) of the participants strongly agreed that “HPV would be a severe threat to my sex life.” Cumulatively, our sample responded with an average score of 18.73 out of a possible 35 for all 5 statements used to measure perceived risk (Table 3).

Table 2. Human papillomavirus (HPV) perceived risk among sexual and gender minorities (N=47).
HPV would be a severe threat to my sex life, n (%)HPV would be a severe threat to my health, n (%)HPV would be a serious threat to the quality of my life, n (%)I am at high risk for getting HPV, n (%)I am likely to get HPV, n (%)
Strongly agree13 (27.70)7 (14.90)11 (23.40)5 (10.60)4 (8.51)
Agree12 (25.50)10 (21.30)8 (17.00)3 (6.40)4 (8.51)
Slightly agree8 (17.00)10 (21.30)6 (12.80)4 (8.50)4 (8.51)
Not sure9 (19.10)14 (29.80)13 (27.70)9 (19.10)13 (27.66)
Slightly disagree1 (2.10)3 (6.40)4 (8.50)4 (8.50)2 (4.26)
Disagree3 (6.40)2 (4.30)4 (8.50)10 (21.30)9 (19.15)
Strongly disagree1 (2.10)0 (0.00)1 (2.10)12 (25.50)11 (23.40)
Table 3. Distribution of perceived risk of human papillomavirus (HPV) scores among participants. Higher scores indicate a greater perceived risk of HPV. Score ranges reflect grouped responses based on participants’ self-assessment. Percentages are based on the total sample (N=47).
RangeValues, n (%)
Less than 154 (8.5)
16‐1915 (32)
20‐2314 (29.7)
24‐277 (14.8)
28‐355 (10.6)

Qualitative Findings

Participant interviews revealed that “Real Outcomes,” and “Accurate Representation” were the main components that should be considered for inclusion in an HPV documentary tailored for sexual and gender minority populations. Interviewees also revealed insights into their unique “Health Care Experiences” and the “Importance of using social media to disseminate information.”

Health Care Experiences

Participants discussed the quality of the health care they have received as well as their exposure to health information. Health care providers see a variety of patients daily and therefore have a higher possibility of exposing individuals to health information [Technical series on safer primary care: patient engagement. World Health Organization. URL: https://www.who.int/publications-detail-redirect/9789241511629 [Accessed 2024-05-03] 53]. However, according to the accounts relayed by the participants, providers and health systems are doing little to take advantage of that opportunity. As one participant described, they received health information rarely, or only when they asked questions.

As far as suburban Atlanta goes, it’s much more difficult, right? Because, whenever you go into doctors’ clinics or stuff sometimes there are pamphlets, but sometimes there’s just not that much information. It’s like a, if you ask them, you get information sort of basis. It’s not, you can- they’ll tell you, without asking.

Participants’ expressions of the quality of care they have received from their health care providers varied (Textbox 1). Participants preferred to use LGBTQ + friendly health care providers and clinics, with some mentioning that the major barrier faced was race, not sexuality. This is exemplified in the quote below:

Yeah, I try to go to, I think something basic, like STD testing or like a routine checkup, yeah I try to go to the queer friendly spaces or places that are queer-affiliated. Um, where, as if it goes like, if it seems like I can’t handle it in urgent care, um I still try to avoid going to X clinic, because every single time I’ve been there it’s been trash treatment. And just the big bill, so first I’ll start with if I can’t do it with urgent care or like queer-friendly spaces, I will just try a new hospital. Is my new thing so yeah. Only a stigma I’m working against you know just being black, even in a predominantly black city.
Textbox 1. Participant quotes on health care experiences (health information exposure and quality of care).

Health information exposure:

  • Both at the clinic, and there’s a there’s a like a truck that comes by, I guess, where you can also do it certain days of the month, things like that. So, I feel like for on campus people, it’s a lot easier to get information, even if you’re not necessarily looking for it.
  • It just kind of seemed a little ridiculous, like um because I don’t know much about healthcare, and I don’t know much about testing so to have to ask her was like, a lot because I didn’t even know what to ask for. I was just like; do you have any other tests? And she was like oh yeah, do you want to like get this test done, I was like yeah, are there any other ones? Like, I’ll get all of them done.
  • I mean I access the, you know, I get messages through like the telehealth portals and things like that around, um, different things that I’m asking about, um. I don’t think I really got much. I mean, I remember picking up a couple of brochures here and there about like the HPV vaccine, and different stuff, and reading them at the clinic.
  • I just felt like she, you know, she really talks about you know how I can prevent certain things like you know here [are] some resources for you to look at you know if you ever needed like that she you know she was the one that pointed me towards the health department if I ever need any like STI testing...overall she’s providing a lot of information about different things about you know how to stay healthy, in general...

Quality of care:

  • I don’t like going to the doctor, I very much avoid it, that can be kind of hard to nail down. Just because I’ve just been rubbed so wrong by going in and just constantly having to either a) explain my whole history again, um b) it’s just obvious through their mood or tone that they don’t respect me, or see me, as you know. They’re just uncomfortable being around me. Like, I was you know it’s very hard. It’s like, I’m now at the point where it’s like, 'okay, the doctor has to prove to me that I can trust them’.
  • It really depends on where I go and if I get lucky or not.
  • I think the major differences that doctor is inside the city of Atlanta, so. Most doctors that I see that are inside the city of Atlanta, the likelihood kind of shoots way up that I’m going to have an okay experience, but the further outside of Atlanta I go, the more likely, I am just sort of you know, have to explain things that are unrelated to my being there.

Many of the participants shared that they avoid visiting their doctor due to past negative experiences, as well as discussed how they felt their health care providers needed to earn their trust before they could be completely open with their health care needs. The participants’ experiences highlight the need to improve the consistency of high-quality health care.

Dissemination

The participants indicated the importance of using social media as a channel for disseminating DST products (Textbox 2). The information should be presented in a manner that does not overwhelm viewers and is easy to understand, so that viewers are left satisfied with what they have learned. Participants highlighted the need for information to be just enough that it was not overwhelming and provided key takeaways.

Textbox 2. Participant quotes on dissemination (digital storytelling and use of social media).

Digital storytelling:

  • I will say, those that dive into the more human and emotional side. You know, especially when you’re dealing with those [who] are being affected by certain things, and it kind of, kind of pulls you in.
  • If you have it shorter, you can reach more people, but when you have it longer you have more of a chance to make a higher impact. So, I feel like there are definitely advantages to both, so if you actually did both, then you could use one as a segue into the other.
  • I think I’d go stay away from doing like the you know, like the really sort of tragic/emotional music, I guess, if you’re trying to lessen the stigma um more of just probably something more like trying to normalize it, have people living like their daily lives and stuff maybe like just slice of life type thing.

Social media:

  • Popular social media websites. Like, the most successful sort of like, videos and stuff I’ve ended up like, seeing I guess like for like vitalities purposes, like going viral and whatever is like. If I follow people on like, multiple social media platforms, where, even if I don’t, and I see that video pop up more than once, or that sort of article or whatever I’m way more likely to see it.
  • I think it’d be better to if it was shorter too. Somehow get it on social media and just get make it somehow get it to be viral honestly. So, it’s got [to be] super catchy.
  • Honestly, I would say number one is like, the Internet. Um, and like, social media in general, just because um, speaking of the context of growing up in the South, like I, the first place, that I learned to go to look for LGBT like information at all, let alone LGBT healthcare is the Internet.
Have it be like hey, this is what this is, this is what it can do and just present the facts in an easy to understand manner, where people don’t feel overwhelmed by the information and just laying it out for people in a way that they can understand that they don’t have to go and do all of their like you do the research for them, and you say like here, it is, and this nice little bundle so you can take it away...

Participants describe how they are drawn towards human and emotional perspectives in what they watch, especially when it comes to stories involving life experiences. The participants’ overall suggestions for DST include the importance of presentation, length of the videos or film, and sharing true stories that express emotion and highlight humanity. In relation to modes of dissemination, one participant shared that much of the information they learned relating to the LGBTQ+ community was via web-based mediums. Social media connects people who are like them and provides a safe place for those who do not have a safe place in real life. Because of this reason, it proved to be an optimal channel identified by participants as seen below:

I would say, social media is pretty big honestly. Like a lot of people who feel like they don’t have voices in real life, I think, are more willing or feel more comfortable reaching out through social media. And I think, from your point of view, as someone who wants to provide more education and information and stuff. I think social media would be a great platform.

Creating something as simple as a few short videos that provide health information and keep the interest of the viewer, and make it easy to share across multiple platforms, can increase the number of views and potentially lead to the videos going viral.

Representation

Accurate representation of the LGBTQ+ community was another theme that arose during the interviews (Textbox 3). Participants noted that there is a substantial difference between the media’s prototypical LGBTQ+ persona and the actual modern-day lives that they live. Accurately capturing their reality would be vital to increasing their engagement. Several of them noted that when they saw themselves being represented in popular sitcoms and television shows, their interest in that show or character increased instantly. Furthermore, it was noted that this representation should also encompass what it looks like to live with HPV, as well as diversity in terms of cultural backgrounds and races, as described by one participant:

I would say, you know include all different race of people. Um, and not just that one kind. Um, you know, mix it up a bit. You know, black, white, Afr- I mean, Chinese, Japanese, Korean, Asian you know, go outside the normal box. You know, all sizes um, male, female, transgender. Um, just like ready to go out there, all ages.
Textbox 3. Participant quotes on representation (race and accurate representation of being LGBTQ+ [lesbian, gay, bisexual, transgender, queer/questioning]).

Representation:

  • We should be represented in a way that includes all races. All, I would say, like all guys and females we’re not all the same, and some people, you can’t even look at them and know that you know that they’re like gay or that they’re even sick, you know.
  • I would say, you know include all different race of people. Um, and not just that one kind. Um, you know, mix it up a bit. You know, black, white, Afr- I mean, Chinese, Japanese, Korean, Asian you know, go outside the normal box. You know, all sizes um, male, female, transgender. Um, just like ready to go out there, all ages.
  • I think it’s definitely important to include some race representation. Because most, most race, they’re probably going to be like ’Oh. this isn’t for me’ and just turn it off or, or not pay attention, but finding a way to connect, to, including ace representation. Um, and why it’s important to think about, even if you’re not sexually active.

Doing so would provide a common experience that participants felt would allow them to foster a greater connection with the topic, in addition to providing increased optimism and hope for those living with the disease.

Messaging

Participants also noted the importance of highlighting real outcomes when speaking about HPV. Notable perspectives mentioned the need to demonstrate not only the prevalence of the disease but also to demystify the disease to the general population. Various complications can arise from being infected with HPV; from cervical cancer, anal and penile cancer to more benign problems such as warts.

Someone who has lived through it, or is living through it, or had to care for someone who had it, etc, or someone who even had it advance all the way to, to ovarian cancer or you know however it may affect men. That would be definitely attention grabbing.

According to the participants, including this wide range of problems would be engaging and allow the audience to graphically connect with the importance of being vaccinated. They also mentioned that having caregivers or family members share their viewpoints would also be beneficial to connecting with the intended audience (Textbox 4).

Textbox 4. Participant quotes on messaging (importance of real outcomes).

Real outcomes:

  • Look for somebody that can make a case for getting vaccinated, you know. As well, somebody that- that has it and has had a lot of problems with it. Oh, you know I’ve had to do, you know, I had HPV and it turned to cervical cancer and I had to you know have my cervix removed... You know, and now I can never have children, I can’t you know, whatever because of this, you know get vaccinated. And so, make it a little bit somebody that can talk kind of graphically, just like I just grabbed your attention with just that though.
  • It’s not necessarily separate from you, um, like if you’re not sexually active, then I can see how that would be kind of separate from you, but it could still happen to someone that you care about or it could, if you’re sexually active it can definitely happen to you.
  • So, it’s like if you can’t make that personal connection, if you can’t you don’t think anyone around you has it, you think like, oh well, it’s not a real problem, or like, yeah. So, I think that’s just confusing because, obviously, people do have it so there’s it’s more of like a silent thing, where people just aren’t talking about it. Yeah, so kind of connecting that and making people realize that people do have it, they just don’t talk about it would be nice, I guess.

Principal Findings

Our goal within this study was to identify what characteristics are essential to include in the development of HPV-related vaccination intervention for an LGBTQ+ audience and to identify dissemination methods that would ensure virality. This study has highlighted 2 key items to include in digital stories: real outcomes and representation.

Comparison to Prior Work

Past research surrounding patient narratives has shown them to be a useful tool to gather information, communication, engagement, persuasion, and health behavior change [Park E, Forhan M, Jones CA. The use of digital storytelling of patients’ stories as an approach to translating knowledge: a scoping review. Res Involv Engagem. Aug 28, 2021;7(1):58. [CrossRef] [Medline]54]. DST expands upon the utility of patient narratives through its ability to focus on capturing the experiences of populations to share findings in an engaging manner through digital media [Rieger KL, West CH, Kenny A, et al. Digital storytelling as a method in health research: a systematic review protocol. Syst Rev. Mar 5, 2018;7(1):41. [CrossRef] [Medline]34]. However, the use of DST has some trade-offs with health care professionals arguing that the quality or accuracy of media-based DST is a major concern due to their lack of medical expertise [Park E, Forhan M, Jones CA. The use of digital storytelling of patients’ stories as an approach to translating knowledge: a scoping review. Res Involv Engagem. Aug 28, 2021;7(1):58. [CrossRef] [Medline]54]. Thus, the creation of any DST method for any behavioral intervention should allow for the opportunity to collaborate with health care professionals to ensure the provision of reliable, evidence-based medical guidance.

Results from our formative inquiry support the well-reported health disparities that the LGBTQ+ population frequently experiences, such as stigma and discrimination from health care providers [George MA. Queering reproductive justice. U Rich L Rev. 2020;54(3). URL: https://scholarship.richmond.edu/lawreview/vol54/iss3/2 [Accessed 2025-05-15] 43-Russell C. Rights-holders or refugees? do gay men need reproductive justice? Reprod Biomed Soc Online. Nov 2018;7:131-140. [CrossRef] [Medline]46]. Stigma and discrimination in health care settings undermine effective communication, which is essential for delivering quality care and fostering self-confidence. When comparing the communication and care quality between races, researchers found that Hispanic and Asian survivors reported poorer communication than White cancer providers, with Asians also reporting poorer care quality [Jenerette CM, Mayer DK. Patient-provider communication: the rise of patient engagement. Semin Oncol Nurs. May 2016;32(2):134-143. [CrossRef] [Medline]55].

There is a pattern of discrimination, stigma, and lack of awareness among health care providers that has impeded LGBTQ+ populations from accessing health care services and has had a major impact on their health [Carpenter E. “The Health System Just Wasn’t Built for Us”: queer cisgender women and gender expansive individuals’ strategies for navigating reproductive health care. Womens Health Issues. 2021;31(5):478-484. [CrossRef] [Medline]41] resulting in less sexually transmitted disease screenings, inappropriate contraceptive counseling, less contraceptive use, and misinformation on sexual education and reproductive promotion. For example, studies have shown that lesbian women have lower use of sexual and reproductive health services, leading to significantly lower rates of pap smear testing [Quinn GP, Sanchez JA, Sutton SK, et al. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA Cancer J Clin. 2015;65(5):384-400. [CrossRef] [Medline]56]. Additionally, the Center for Disease Control has reported that 71% of new HIV infections seen were among gay and bisexual men in the United States in 2022 [Fast facts: HIV and gay and bisexual men. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/hiv/data-research/facts-stats/gay-bisexual-men.html [Accessed 2024-11-21] 57]. The use of DST within this population would allow for increased engagement and connections with others (ie, patients, advocacy groups, caregivers, health care professionals, and policy makers) that share similar lived experiences. Furthermore, through sharing their unique stories via this method, they can alter preconceived notions about their susceptibility/risk, attack misinformation concerning vaccinations, and reduce the health care disparities seen, thus improving the overall health of the LGBTQ+ population.

Strengths and Limitations

Several limitations exist within the study. First, our sampling methodology could be a limitation [Galdas P. Revisiting bias in qualitative research: reflections on its relationship with funding and impact. Int J Qual Methods. 2017;16(1). [CrossRef]58]. We used voluntary convenience sampling to recruit study participants [Elfil M, Negida A. Sampling methods in clinical research; an educational review. Emerg (Tehran). 2017;5(1):e52. [Medline]59]. It is argued that this type of nonprobability sampling is not truly representative of the entire population, as the sample is likely to overrepresent or underrepresent certain groups and mainly targets persons with stronger opinions. Furthermore, this method has a low external validity and a lack of transferability to other populations [Jager J, Putnick DL, Bornstein MH. II. More than just convenient: the scientific merits of homogeneous convenience samples. Monogr Soc Res Child Dev. Jun 2017;82(2):13-30. [CrossRef] [Medline]60]. Future research should consider partnering with community organizations during the recruitment period, thus diversifying participant groups and perspectives. Second, our cohort was concentrated within the Atlanta area. Atlanta has a unique demographic, cultural, and public health characteristic, which includes a greater exposure to public health campaigns that may influence overall health behaviors and beliefs. DST interventions conducted in other states/ countries may encounter alternative barriers or facilitators to HPV vaccination and thus may discover that other elements may need to be included.

A more in-depth analysis of the resulting themes could have yielded a deeper understanding of participant viewpoints and their implications. While we used a mixed methods research design, we failed to triangulate the data collection due to the practical constraints related to participant recruitment, such as patient and researcher availability and stringent COVID-19 protocols. As a result, the conclusions and insights from the participants were based on a single approach, thus limiting their validity. Additionally, as we did not collect or analyze data regarding differences in findings between vaccination status and other characteristics, which limited our ability to explore how the perceived risk of HPV may vary across subgroups. Future research should consider analyzing this area in order to not only provide a deeper understanding of the effect that individual factors may have on perceived risk but also provide insight into how to tailor public health interventions.

Conclusions

The LGBTQ+ community is often misrepresented, underrepresented, or not at all represented in media, nor do they often feel safe and comfortable enough to share their experiences with others outside of their community. The use of DST methods involving real outcomes and accurate representation would bridge the gap created by stigmatization in order to improve HPV vaccination adherence and reduce health care disparities within this population.

Acknowledgments

The authors would like to acknowledge the contributions of all undergraduate students (Fatima Alarcon-Tinoco, Zaira Khan, and Danielle Hawk) who assisted in the collection of data for the study. This study was made possible through the financial support of Mercer University’s Provost Office Seed Grant.

Data Availability

The datasets generated or analyzed during this study are available from the corresponding author on reasonable request.

Authors' Contributions

All authors agree to be accountable for all aspects of the work. GD-S, BS, UI, JN, CM, and PT were responsible for the concept and design of the study. GD-S, DM, EC, and UI contributed to the acquisition, analysis, or interpretation of the data. All authors participated in drafting the manuscript and provided critical revisions for important intellectual content. Statistical analysis was performed by GD-S, DM, EC, and UI. All authors have read and approved the final version of the manuscript.

Conflicts of Interest

None declared.

  1. Nandi A, Shet A. Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination. Hum Vaccin Immunother. Aug 2, 2020;16(8):1900-1904. [CrossRef] [Medline]
  2. Orenstein WA, Ahmed R. Simply put: vaccination saves lives. Proc Natl Acad Sci U S A. Apr 18, 2017;114(16):4031-4033. [CrossRef] [Medline]
  3. Rodrigues CMC, Plotkin SA. Impact of vaccines; health, economic and social perspectives. Front Microbiol. 2020;11:1526. [CrossRef] [Medline]
  4. Hirth J. Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature. Hum Vaccin Immunother. 2019;15(1):146-155. [CrossRef] [Medline]
  5. Lewis RM, Laprise JF, Gargano JW, et al. Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States. Sex Transm Dis. Apr 1, 2021;48(4):273-277. [CrossRef] [Medline]
  6. McClung NM, Gargano JW, Park IU, et al. Estimated number of cases of high-grade cervical lesions diagnosed among women - United States, 2008 and 2016. MMWR Morb Mortal Wkly Rep. Apr 19, 2019;68(15):337-343. [CrossRef] [Medline]
  7. Chido-Amajuoyi OG, Jackson I, Yu R, Shete S. Declining awareness of HPV and HPV vaccine within the general US population. Hum Vaccin Immunother. Feb 1, 2021;17(2):420-427. [CrossRef] [Medline]
  8. Etowa J, Beauchamp S, Fseifes M, et al. Understanding low vaccine uptake in the context of public health in high-income countries: a scoping review. Vaccines (Basel). Mar 4, 2024;12(3):269. [CrossRef] [Medline]
  9. Alcendor DJ. Targeting COVID vaccine hesitancy in rural communities in Tennessee: implications for extending the COVID-19 pandemic in the south. Vaccines (Basel). Nov 4, 2021;9(11):1279. [CrossRef] [Medline]
  10. Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger JA. Vaccine hesitancy. Hum Vaccines Immunother. Aug 8, 2013;9(8):1763-1773. [CrossRef]
  11. Garett R, Young SD. Online misinformation and vaccine hesitancy. Transl Behav Med. Dec 14, 2021;11(12):2194-2199. [CrossRef] [Medline]
  12. Oostvogel PM, van Wijngaarden JK, van der Avoort HG, et al. Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93. Lancet. Sep 3, 1994;344(8923):665-670. [CrossRef] [Medline]
  13. Hou Z, Tong Y, Du F, et al. Assessing COVID-19 vaccine hesitancy, confidence, and public engagement: a global social listening study. J Med Internet Res. Jun 11, 2021;23(6):e27632. [CrossRef] [Medline]
  14. Nuwarda RF, Ramzan I, Weekes L, Kayser V. Vaccine hesitancy: contemporary issues and historical background. Vaccines (Basel). Sep 22, 2022;10(10):1595. [CrossRef] [Medline]
  15. Ten health issues WHO will tackle this year. World Health Organization. URL: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 [Accessed 2023-09-21]
  16. Kulenkampff M, Schwartzman JS, Wilson J. Neurological complications of pertussis inoculation. Arch Dis Child. Jan 1974;49(1):46-49. [CrossRef] [Medline]
  17. GBS (guillain-barré syndrome) and vaccines | vaccine safety. Center for Disease Control. URL: https://www.cdc.gov/vaccinesafety/concerns/guillain-barre-syndrome.html [Accessed 2023-09-21]
  18. Historical safety concerns | vaccine safety. Center for Disease Control. URL: https://www.cdc.gov/vaccinesafety/concerns/concerns-history.html [Accessed 2023-09-21]
  19. Stephens AB, Hofstetter AM, Stockwell MS. Influenza vaccine hesitancy: scope, influencing factors, and strategic interventions. Pediatr Clin North Am. Apr 2023;70(2):227-241. [CrossRef] [Medline]
  20. Rittle C. COVID-19 vaccine hesitancy and how to address it. Workplace Health Saf. Feb 2022;70(2):56-62. [CrossRef] [Medline]
  21. Yasmin F, Najeeb H, Moeed A, et al. COVID-19 vaccine hesitancy in the United States: a systematic review. Front Public Health. 2021;9:770985. [CrossRef] [Medline]
  22. Amantea C, Foschi N, Gavi F, et al. HPV vaccination adherence in working-age men: a systematic review and meta-analysis. Vaccines (Basel). Feb 15, 2023;11(2):443. [CrossRef] [Medline]
  23. Ejezie CL, Osaghae I, Ayieko S, Cuccaro P. Adherence to the recommended HPV vaccine dosing schedule among adolescents aged 13 to 17 years: findings from the national immunization survey-teen, 2019-2020. Vaccines (Basel). Apr 8, 2022;10(4):577. [CrossRef] [Medline]
  24. Bednarczyk RA, Ellingson MK, Omer SB. Human papillomavirus vaccination before 13 and 15 years of age: analysis of national immunization survey teen data. J Infect Dis. Jul 31, 2019;220(5):730-734. [CrossRef] [Medline]
  25. Walker TY, Elam-Evans LD, Singleton JA, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2016. MMWR Morb Mortal Wkly Rep. Aug 25, 2017;66(33):874-882. [CrossRef] [Medline]
  26. Hirth JM, Rahman M, Smith JS, Berenson AB. Regional variations in HPV vaccination among 9–17 year old adolescent females from the BRFSS, 2008–2010. Hum Vaccines Immunother. Dec 2, 2014;10(12):3475-3483. [CrossRef]
  27. Rahman M, McGrath CJ, Berenson AB. Geographic variation in human papillomavirus vaccination uptake among 13-17 year old adolescent girls in the United States. Vaccine (Auckl). May 1, 2014;32(21):2394-2398. [CrossRef] [Medline]
  28. Kurani S, MacLaughlin KL, Jacobson RM, et al. Socioeconomic disadvantage and human papillomavirus (HPV) vaccination uptake. Vaccine (Auckl). Jan 24, 2022;40(3):471-476. [CrossRef] [Medline]
  29. Rosen BL, Shepard A, Kahn JA. US health care clinicians’ knowledge, attitudes, and practices regarding human papillomavirus vaccination: a qualitative systematic review. Acad Pediatr. Mar 2018;18(2S):S53-S65. [CrossRef] [Medline]
  30. Esaggoff A, Cohen, S, Chang G, Equils O, Orman SV, Burnett A. 2531. using peer-to-peer education to increase awareness and uptake of HPV vaccine among Chinese international students. Open Forum Infect Dis. Oct 23, 2019;6(Supplement_2):S879-S880. [CrossRef]
  31. Flowers P, Hart GJ, Williamson LM, Frankis JS, Der GJ. Does bar-based, peer-led sexual health promotion have a community-level effect amongst gay men in Scotland? Int J STD AIDS. Feb 2002;13(2):102-108. [CrossRef] [Medline]
  32. Ganczak M, Pasek O, Duda-Duma Ł, Komorzycka J, Nowak K, Korzeń M. A peer-based educational intervention effects on SARS-CoV-2 knowledge and attitudes among Polish high-school students. Int J Environ Res Public Health. Nov 20, 2021;18(22):12183. [CrossRef] [Medline]
  33. Tutt M, Begay C, George S, et al. Diné teachings and public health students informing peers and relatives about vaccine education: providing Diné (Navajo)-centered COVID-19 education materials using student health messengers. Front Public Health. 2022;10:1046634. [CrossRef] [Medline]
  34. Rieger KL, West CH, Kenny A, et al. Digital storytelling as a method in health research: a systematic review protocol. Syst Rev. Mar 5, 2018;7(1):41. [CrossRef] [Medline]
  35. Villanti AC, Johnson AL, Ilakkuvan V, Jacobs MA, Graham AL, Rath JM. Social media use and access to digital technology in US young adults in 2016. J Med Internet Res. Jun 7, 2017;19(6):e196. [CrossRef] [Medline]
  36. Lehtimaki S, Martic J, Wahl B, Foster KT, Schwalbe N. Evidence on digital mental health interventions for adolescents and young people: systematic overview. JMIR Ment Health. Apr 29, 2021;8(4):e25847. [CrossRef] [Medline]
  37. Young people and digital health interventions: working together to design better. World Health Organization. URL: https:/​/www.​who.int/​news/​item/​29-10-2020-young-people-and-digital-health-interventions-working-together-to-design-better [Accessed 2024-03-05]
  38. Budhwani H, Maragh-Bass AC, Tolley EE, et al. Tough talks COVID-19 digital health intervention for vaccine hesitancy among Black young adults: protocol for a hybrid type 1 effectiveness implementation randomized controlled trial. JMIR Res Protoc. Feb 13, 2023;12(1):e41240. [CrossRef] [Medline]
  39. Kim M, Lee H, Kiang P, et al. A storytelling intervention in a mobile, web-based platform: a pilot randomized controlled trial to evaluate the preliminary effectiveness to promote human papillomavirus vaccination in Korean American college women. Health Educ Behav. Apr 2020;47(2):258-263. [CrossRef] [Medline]
  40. Chen ACC, Kim WS, Todd M, Larkey L. A digital storytelling intervention for Vietnamese American mothers to promote their children’s HPV vaccination. Cancer Prev Res (Phila). Jul 5, 2022;15(7):465-472. [CrossRef] [Medline]
  41. Carpenter E. “The Health System Just Wasn’t Built for Us”: queer cisgender women and gender expansive individuals’ strategies for navigating reproductive health care. Womens Health Issues. 2021;31(5):478-484. [CrossRef] [Medline]
  42. Fredriksen-Goldsen KI, Simoni JM, Kim HJ, et al. The health equity promotion model: reconceptualization of lesbian, gay, bisexual, and transgender (LGBT) health disparities. Am J Orthopsychiatry. Nov 2014;84(6):653-663. [CrossRef] [Medline]
  43. George MA. Queering reproductive justice. U Rich L Rev. 2020;54(3). URL: https://scholarship.richmond.edu/lawreview/vol54/iss3/2 [Accessed 2025-05-15]
  44. Loza O, Alvarez CR, Peralta-Torres D. Healthcare and social services providers who serve sexual and gender minorities in a U.S.-Mexico border city. J Immigrant Minority Health. Dec 2018;20(6):1537-1540. [CrossRef]
  45. Mayer KH, Bradford JB, Makadon HJ, Stall R, Goldhammer H, Landers S. Sexual and gender minority health: what we know and what needs to be done. Am J Public Health. Jun 2008;98(6):989-995. [CrossRef] [Medline]
  46. Russell C. Rights-holders or refugees? do gay men need reproductive justice? Reprod Biomed Soc Online. Nov 2018;7:131-140. [CrossRef] [Medline]
  47. Ward BW, Dahlhamer JM, Galinsky AM, Joestl SS. Sexual orientation and health among U.S. adults: national health interview survey, 2013. Natl Health Stat Report. Jul 15, 2014;(77):1-10. [Medline]
  48. SuperSaaS. URL: https://www.supersaas.com [Accessed 2024-03-07]
  49. Katz ML, Kam JA, Krieger JL, Roberto AJ. Predicting human papillomavirus vaccine intentions of college-aged males: an examination of parents’ and son’s perceptions. J Am Coll Health. 2012;60(6):449-459. [CrossRef] [Medline]
  50. Thomas PD. A qualitative exploration of pre-exposure prophylaxis (PrEP) initiation decision-making among men who have sex with men (MSM): “It Definitely was A Process”. J Natl Black Nurses Assoc. Dec 2019;30(2):10-17. [Medline]
  51. Glaser BG. The constant comparative method of qualitative analysis. Soc Probl. Apr 1965;12(4):436-445. [CrossRef]
  52. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276-282. [CrossRef]
  53. Technical series on safer primary care: patient engagement. World Health Organization. URL: https://www.who.int/publications-detail-redirect/9789241511629 [Accessed 2024-05-03]
  54. Park E, Forhan M, Jones CA. The use of digital storytelling of patients’ stories as an approach to translating knowledge: a scoping review. Res Involv Engagem. Aug 28, 2021;7(1):58. [CrossRef] [Medline]
  55. Jenerette CM, Mayer DK. Patient-provider communication: the rise of patient engagement. Semin Oncol Nurs. May 2016;32(2):134-143. [CrossRef] [Medline]
  56. Quinn GP, Sanchez JA, Sutton SK, et al. Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA Cancer J Clin. 2015;65(5):384-400. [CrossRef] [Medline]
  57. Fast facts: HIV and gay and bisexual men. Centers for Disease Control and Prevention. URL: https://www.cdc.gov/hiv/data-research/facts-stats/gay-bisexual-men.html [Accessed 2024-11-21]
  58. Galdas P. Revisiting bias in qualitative research: reflections on its relationship with funding and impact. Int J Qual Methods. 2017;16(1). [CrossRef]
  59. Elfil M, Negida A. Sampling methods in clinical research; an educational review. Emerg (Tehran). 2017;5(1):e52. [Medline]
  60. Jager J, Putnick DL, Bornstein MH. II. More than just convenient: the scientific merits of homogeneous convenience samples. Monogr Soc Res Child Dev. Jun 2017;82(2):13-30. [CrossRef] [Medline]


DST: digital storytelling
HPV: human papillomavirus
LGBTQ+: lesbian, gay, bisexual, transgender, queer/questioning


Edited by Naomi Cahill; submitted 07.03.24; peer-reviewed by Jennifer Loukissas, Lihong Ou; final revised version received 10.04.25; accepted 15.04.25; published 30.05.25.

Copyright

© Gabrielle Darville-Sanders, Dominique Munroe, Emilie Corluyan, Utibeabasi Ikoiwak, Jennifer Nguyen, Chad Mandula, Portia Thomas, Brandon Sanders. Originally published in JMIR Formative Research (https://formative.jmir.org), 30.5.2025.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.